CLINICAL_TRIALS ClinicalTrials.gov record update

R2810-ONC-16XX: A Phase 1 Neoadjuvant Study of Stereotactic Body Radiation Therapy With Systemic REGN2810 and Intraprostatic Ipilimumab, Alone or in Combination, in Patients With Locally Advanced Prostate Cancer Prior to Radical Prostatectomy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03477864
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:51.976657+00:00
Published At: 2025-04-29T00:00:00+00:00
Record Updated At: 2025-04-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Stage III Prostate Cancer", "Stage IIIA Prostate Cancer", "Stage IIIB Prostate Cancer", "Stage IIIC Prostate Cancer", "Stage IV Prostate Cancer", "Stage IVA Prostate Cancer", "Stage IVB Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-04-29"
protocolSection.identificationModule.nctId: "NCT03477864"
protocolSection.identificationModule.officialTitle: "R2810-ONC-16XX: A Phase 1 Neoadjuvant Study of Stereotactic Body Radiation Therapy With Systemic REGN2810 and Intraprostatic Ipilimumab, Alone or in Combination, in Patients With Locally Advanced Prostate Cancer Prior to Radical Prostatectomy"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.